داروی مسدودکننده عصبی-عضلانی (Persian Wikipedia)

Analysis of information sources in references of the Wikipedia article "داروی مسدودکننده عصبی-عضلانی" in Persian language version.

refsWebsite

Global rank Persian rank

11nih.gov

4^th place

5^th place

7doi.org

2^nd place

3worldcat.org

5^th place

12^th place

1mercksource.com

8,363^rd place

2,760^th place

1archive.org

6^th place

9^th place

archive.org

Rang, H. P. (2003). Pharmacology. Edinburgh: Churchill Livingstone. p. 151. ISBN 978-0-443-07145-4. OCLC 51622037.

doi.org

Lee, C. (2001). "Structure, conformation and action of neuromuscular blocking drugs". British Journal of Anaesthesia. 87 (5): 755–769. doi:10.1093/bja/87.5.755. PMID 11878528.
Bufler J, Wilhelm R, Parnas H, Franke C, Dudel J (1996). "Open channel and competitive block of the embryonic form of the nicotinic receptor of mouse myotubes by (+)-tubocurarine". J. Physiol. 495 (Pt 1): 83–95. doi:10.1113/jphysiol.1996.sp021575. PMC 1160726. PMID 8866353.
Raghavendra, T. (2002). "Neuromuscular blocking drugs: discovery and development". Journal of the Royal Society of Medicine. 95 (7): 363–367. doi:10.1177/014107680209500713. PMC 1279945. PMID 12091515.
W. C. Bowman (2006). "Neuromuscular block". British Journal of Pharmacology. 147 (S1): S277–S286. doi:10.1038/sj.bjp.0706404. PMC 1760749. PMID 16402115.
Inada, E.; Philbin, D. M.; Machaj, V.; Moss, J.; D'Ambra, M. N.; Rosow, C. E.; Akins, C. W. (Winter 1986). "Histamine antagonists and d-tubocurarine-induced hypotension in cardiac surgical patients". Clinical Pharmacology and Therapeutics. 40 (5): 575–580. doi:10.1038/clpt.1986.226. ISSN 0009-9236. PMID 2429800.
Ostergaard, D.; Engbaek, J.; Viby-Mogensen, J. (Fall 1989). "Adverse reactions and interactions of the neuromuscular blocking drugs". Medical Toxicology and Adverse Drug Experience. 4 (5): 351–368. doi:10.1007/BF03259917. ISSN 0113-5244. PMID 2682131.
Paradelis, A. G.; Triantaphyllidis, C.; Logaras, G. (1976). "Neuromuscular Blocking Activity of Aminoglycoside Antibiotics". Pharmacology of Antibiotics. p. 359. doi:10.1007/978-1-4684-3123-0_51. ISBN 978-1-4684-3125-4.

mercksource.com

"Dorlands Medical Dictionary:neuromuscular blocking agent".^{^{[پیوند مرده]}}

nih.gov

pubmed.ncbi.nlm.nih.gov

Lee, C. (2001). "Structure, conformation and action of neuromuscular blocking drugs". British Journal of Anaesthesia. 87 (5): 755–769. doi:10.1093/bja/87.5.755. PMID 11878528.
Bufler J, Wilhelm R, Parnas H, Franke C, Dudel J (1996). "Open channel and competitive block of the embryonic form of the nicotinic receptor of mouse myotubes by (+)-tubocurarine". J. Physiol. 495 (Pt 1): 83–95. doi:10.1113/jphysiol.1996.sp021575. PMC 1160726. PMID 8866353.
Raghavendra, T. (2002). "Neuromuscular blocking drugs: discovery and development". Journal of the Royal Society of Medicine. 95 (7): 363–367. doi:10.1177/014107680209500713. PMC 1279945. PMID 12091515.
W. C. Bowman (2006). "Neuromuscular block". British Journal of Pharmacology. 147 (S1): S277–S286. doi:10.1038/sj.bjp.0706404. PMC 1760749. PMID 16402115.
Inada, E.; Philbin, D. M.; Machaj, V.; Moss, J.; D'Ambra, M. N.; Rosow, C. E.; Akins, C. W. (Winter 1986). "Histamine antagonists and d-tubocurarine-induced hypotension in cardiac surgical patients". Clinical Pharmacology and Therapeutics. 40 (5): 575–580. doi:10.1038/clpt.1986.226. ISSN 0009-9236. PMID 2429800.
Ostergaard, D.; Engbaek, J.; Viby-Mogensen, J. (Fall 1989). "Adverse reactions and interactions of the neuromuscular blocking drugs". Medical Toxicology and Adverse Drug Experience. 4 (5): 351–368. doi:10.1007/BF03259917. ISSN 0113-5244. PMID 2682131.

ncbi.nlm.nih.gov

Bufler J, Wilhelm R, Parnas H, Franke C, Dudel J (1996). "Open channel and competitive block of the embryonic form of the nicotinic receptor of mouse myotubes by (+)-tubocurarine". J. Physiol. 495 (Pt 1): 83–95. doi:10.1113/jphysiol.1996.sp021575. PMC 1160726. PMID 8866353.
Raghavendra, T. (2002). "Neuromuscular blocking drugs: discovery and development". Journal of the Royal Society of Medicine. 95 (7): 363–367. doi:10.1177/014107680209500713. PMC 1279945. PMID 12091515.
W. C. Bowman (2006). "Neuromuscular block". British Journal of Pharmacology. 147 (S1): S277–S286. doi:10.1038/sj.bjp.0706404. PMC 1760749. PMID 16402115.

nlm.nih.gov

Neuromuscular Nondepolarizing Agents در سرعنوان‌های موضوعی پزشکی (MeSH) در کتابخانهٔ ملی پزشکی ایالات متحدهٔ آمریکا
Neuromuscular Depolarizing Agents در سرعنوان‌های موضوعی پزشکی (MeSH) در کتابخانهٔ ملی پزشکی ایالات متحدهٔ آمریکا

worldcat.org

Inada, E.; Philbin, D. M.; Machaj, V.; Moss, J.; D'Ambra, M. N.; Rosow, C. E.; Akins, C. W. (Winter 1986). "Histamine antagonists and d-tubocurarine-induced hypotension in cardiac surgical patients". Clinical Pharmacology and Therapeutics. 40 (5): 575–580. doi:10.1038/clpt.1986.226. ISSN 0009-9236. PMID 2429800.
Ostergaard, D.; Engbaek, J.; Viby-Mogensen, J. (Fall 1989). "Adverse reactions and interactions of the neuromuscular blocking drugs". Medical Toxicology and Adverse Drug Experience. 4 (5): 351–368. doi:10.1007/BF03259917. ISSN 0113-5244. PMID 2682131.
Rang, H. P. (2003). Pharmacology. Edinburgh: Churchill Livingstone. p. 151. ISBN 978-0-443-07145-4. OCLC 51622037.